New heart device aims to zap away irregular heartbeat
NCT ID NCT05164107
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device that uses short bursts of energy (pulsed field ablation) to treat atrial fibrillation, a common heart rhythm problem. The device maps the heart and then delivers energy to specific areas to correct the rhythm. Researchers will enroll 175 people to see if the procedure is safe and works well.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Globe Mapping and Pulsed Field Ablation System (Globe PF System)
What this could lead to
If successful, this could provide a safer, more precise way to treat atrial fibrillation, potentially reducing complications and improving outcomes.
What could go wrong
This is an early pilot study with no control group, so results are preliminary. The procedure carries risks like any heart ablation, including bleeding, heart damage, or irregular heartbeats.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Motol and Homolka University Hospital
RECRUITINGPrague, 150 00, Czechia